FORMS RELATING TO LISTING

FORM F

GEM

Company Information Sheet

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this information sheet, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this information sheet.

Company name : AID Life Science Holdings Limited

Stock code (ordinary shares) : 8088

This information sheet contains certain particulars concerning the above company (the "Company") which is listed on GEM of The Stock Exchange of Hong Kong Limited (the "Exchange"). These particulars are provided for the purpose of giving information to the public with regard to the Company in compliance with the Rules Governing the Listing of Securities on GEM of The Stock Exchange of Hong Kong Limited (the "GEM Listing Rules"). They will be displayed at the GEM website on the Internet. This information sheet does not purport to be a complete summary of information relevant to the Company and/or its securities.

The information in this sheet was updated as of 19 December 2018.

A.

General

Place of incorporation

:

Cayman Islands

Date of initial listing

:

17 April 2000

on GEM

Names of directors

:

Executive Directors:

(please distinguish the

Wu King Shiu, Kelvin (Chairman)

status of the directors

Chan Suet Ngan

- Executive,

Hu Kenneth

Non-Executive or

Qian Alexandra Gaochuan

Independent

Non-Executive)

Non-Executive Director:

Xu Haohao

Independent Non-Executive Directors:

Fong Janie

Yuen Kwok On

Matsumoto Hitoshi

- 1 -

Name(s) of substantial

Number of

shareholder(s) (as such

ordinary

term is defined in rule

shares

1.01 of the GEM

Listing Rules) and

Hong Kong HNA Holding Group Co. Limited (Note 1)

81,818,000

their respective

Abundant Star Ventures Limited (Note 2)

45,454,545

:

interests in the

Vantage Edge Limited (Note 2)

34,090,937

Hero Sign Limited (Note 2)

25,394,400

ordinary shares and

Wu King Shiu, Kelvin (Notes 2 and 3)

114,644,282

other securities of the

Li Mau (Note 3)

114,644,282

Company

Ho Gilbert Chi Hang (Notes 2 and 4)

104,953,082

Chang Tat Joel (Note 2)

104,939,882

Notes :

  • 1. Hong Kong HNA Holding Group Co. Limited is wholly-owned by HNA Financial Holdings International Co., Ltd. ("HNA Financial"). HNA Financial is wholly-owned by Beijing HNA Financial Holdings Co., Ltd. ("Beijing HNA"). Beijing HNA is owned as to approximately 99% by HNA Investment Holding Co., Ltd. ("HNA Investment"). HNA Investment is owned as to approximately 73% by Hainan HNA Holding Co., Ltd ("Hainan HNA"). Hainan HNA is owned as to approximately 51% by HNA Holding Group Co., Ltd ("HNA Holding") and is owned as to approximately 22% by HNA Group Co., Ltd. ("HNA Group"). HNA Holding is wholly-owned by HNA Group. HNA Group is owned as to approximately 70% by Hainan Traffic Administration Holding Co., Ltd. ("Hainan Traffic"). Hainan Traffic is owned as to approximately 50% by Sheng Tang Development (Yangpu)

    Co., Limited ("Sheng Tang"). Sheng Tang is owned as to 35% by Tang Dynasty Development Co., Limited ("Tang Dynasty"). Tang Dynasty is owned as to approximately 98% by Pan-American Aviation Holding Company, which is in turn 100% beneficially owned by Hainan Cihang Charity Foundation, Inc.

  • 2. Abundant Star Ventures Limited ("Abundant Star"), Vantage Edge Limited ("Vantage Edge") and Hero Sign Limited ("Hero Sign") owns 45,454,545, 34,090,937 and 25,394,400 shares of the Company, respectively. Mr. Wu King Shiu, Kelvin, Mr. Ho Gilbert Chi Hang and Mr. Chang Tat Joel are deemed to have interest in 45,454,545, 34,090,937 and 25,394,400 shares of the Company of which Abundant Star, Vantage Edge and Hero Sign are interested by virtue of the SFO since they indirectly own 56% through Billion Power Management Limited, 23% through Elite Honour Investments Limited and 21% through Genius Link Assets Management Limited, respectively, of the issued share capital of AID Partners GP2, Ltd.. AID Partners GP2, Ltd. is the general partner of AID Partners Capital II, L.P.. AID Partners Capital II, L.P. is a private equity fund interested in the entire issued share capital of Leader Fortune International Limited, which is interested in the entire issued share capital of Abundant Star, Vantage Edge and Hero Sign.

  • 3. Mr. Wu King Shiu, Kelvin owns 1,424,400 shares of the Company and Billion Express Consultants Limited ("Billion Express") owns 8,280,000 shares of the Company. The entire issued share capital of Billion Express is wholly owned by HMV Asia Limited, which is in turn 65.62% beneficially owned by Ms. Li Mau, the spouse of Mr. Wu King Shiu, Kelvin. Accordingly, Mr. Wu King Shiu, Kelvin is deemed to be interested in the shares of the Company held by Billion Express. Mr. Wu King Shiu, Kelvin and Ms. Li Mau are also deemed to have interest in 104,939,882 shares of the Company as mentioned in Note 2 above.

  • 4. Mr. Ho Gilbert Chi Hang owns 13,200 shares of the Company. Mr. Ho Gilbert Chi Hang is also deemed to have interest in 104,939,882 shares of the Company as mentioned in Note 2 above.

- 2 -

Name(s) of company(ies) listed on GEM or the Main Board of the Stock Exchange within the same group as the Company

  • : NilFinancial year end date

  • : 31 December

    Registered address

  • : Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands

    Head office and principal place of business

  • : 22/F., New World Tower II, 18 Queen's Road Central, Central, Hong Kong

    Web-site address (if applicable)

  • :www.8088inc.com

    Share registrar

  • : Computershare Hong Kong Investor Services Limited

    Auditors

  • : BDO Limited

B.

Business activities

AID Life Science Holdings Limited (the "Company" and, together with its subsidiaries, the "Group") is a strategic investment group listed on GEM (stock code: 8088).

The Group is principally engaged in the business of strategic investment.

C.

Ordinary Shares

Number of ordinary share in issue

:

540,232,005

Par value of ordinary shares in issue

:

US$0.002

Board lot size (in number of shares)

:

8,000

Name of other stock exchange(s) on

:

Nil

which ordinary shares are also listed

- 3 -

  • D. Warrants

    Stock code

    :

    N/A

    Board lot size

    :

    N/A

    Expiry date

    :

    N/A

    Exercise price

    :

    N/A

    Conversion ratio (Not applicable

    :

    N/A

    if the warrant is denominated in

    dollar value of conversion right)

    No. of warrants outstanding

    :

    N/A

    No. of shares falling to be issued

    :

    N/A

    upon the exercise of outstanding

    warrants

  • E. Other securities

Details of any other securities in issue:

(i.e. other than the ordinary shares described in C above and warrants described in D above but including options granted to executives and/or employees).

8% Coupon Convertible Bonds Due 2020

No. of shares

Principal

Conversion

to be issued

Issue date

amount

price

upon conversion

HK$

HK$

20 July 2015

140,000,000

6.50

21,538,461

- 4 -

The Convertible Bonds are convertible at the option of the bondholder(s) at any business day during the period commencing from the date falling on the first anniversary of the issue date (i.e. 20 July 2015) up to and including the date which is seven days prior to the maturity date of

20 July 2020, into new ordinary shares of the Company at conversion price at HK$6.50 per share. With the prior notification to the Company, the Convertible Bonds may be transferrable in integral multiples of HK$1,000,000. No transfer of the Convertible Bond(s) to the Prohibited Transferee(s) will be permissible and in the case of any transfer to a connected person of the Company, such transfer will be permitted if the prior written consent of the Company is to be obtained. The Company may, having given not less than thirty (30) days' notice (which notices shall be irrevocable) to the Bondholders, redeem the Convertible Bonds then outstanding in integral multiples of HK$1,000,000, at a premium of 10% above the outstanding principal amount of the Convertible Bonds to be redeemed, on the date specified in the said notice at the outstanding principal amount of the Convertible Bonds to be redeemed at any time prior to the maturity date. For details, please refer to the Company's announcement dated 6 July 2015.

Share Options (pursuant to the share option scheme adopted on 27 March 2002)

Options

Date of

Options

Outstanding

exercisable as at

options granted

exercise price

options

19 December 2018

HK$

29 December 2008

4.40

40,916

40,916

7 October 2010

4.00

118,528

118,528

16 March 2012

4.00

267,129

267,129

14 May 2012

3.80

292,968

292,968

719,541

719,541

Share Options (pursuant to the share option scheme adopted on 15 April 2014)

Options

Date of

Options

Outstanding

exercisable as at

options granted

exercise price

options

19 December 2018

HK$

15 May 2014

3.20

2,734,200

2,734,200

20 June 2014

3.20

3,393,400

3,393,400

1 April 2016

4.94

10,270,800

10,270,800

19 May 2017

1.56

17,109,600

17,109,600

33,508,000

33,508,000

- 5 -

Attachments

  • Original document
  • Permalink

Disclaimer

Healthoo International Technology Holdings Limited published this content on 19 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 December 2018 11:14:06 UTC